Sarcomas and other rare tumors are not included
  • American Joint Committee on Cancer

Summary of Changes

The definition of TNM and the Stage Grouping for this chapter have not changed from the Fifth Edition.


Verrucous Carcinoma Mucinous Cystadenocarcinoma Aortopulmonary Window Pleomorphic Carcinoma Multiple Primary Tumor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. D’Amico TA, Aloia TA, Moore M-BH, et al: Molecular biologic substaging of Stage I lung cancer according to gender and histology. Ann Thorac Surg 69:882–886, 2000PubMedCrossRefGoogle Scholar
  2. Deschamps C, Pairolero PC, Trastek VF, Payne WS: Multiple primary lung cancers: results of surgical treatment. J Thorac Cardiovasc Surg 99:769–778, 1990PubMedGoogle Scholar
  3. Deslauriers J, Brisson J, Cartier R, et al: Carcinoma of the lung: evaluation of satellite nodules as a factor influencing prognosis after resection. J Thorac Cardiovasc Surg 97:504–512, 1989PubMedGoogle Scholar
  4. Ichinose Y, Yano T, Yokoyama H, Inoue T, Asoh H, Katsuda Y: The correlation between tumor size and lymphatic vessel invasion in resected peripheral stage I non-small-cell lung cancer. A potential risk of limited resection. J Thorac Cardiovasc Surg 108:684–686, 1994PubMedGoogle Scholar
  5. Martini N, Flehinger BJ, Zaman MB, Beattie EJ, Jr.: Results of resection in non-oat cell carcinoma of the lung with mediastinal lymph node metastases. Ann Surg 198:386–397, 1983PubMedCrossRefGoogle Scholar
  6. Martini N, Melamed MR: Multiple primary lung cancers. J Thorac Cardiovasc Surg 70:606–612, 1975PubMedGoogle Scholar
  7. Martini N, Yellin A, Ginsberg RJ, et al: Management of non-small cell lung cancer with direct mediastinal involvement. Ann Thorac Surg 58:1447–1451, 1994PubMedCrossRefGoogle Scholar
  8. Patterson GA, Piazza D, Pearson FG, et al: Significance of metastatic disease in subaortic lymph nodes. Ann Thorac Surg. 43:155–159, 1987PubMedCrossRefGoogle Scholar
  9. Pitz CCM, de la Riviere AB, Elbers HRJ, Westermann CJJ, van den Bosch JM: Results of resection of T3 non-small cell lung cancer invading the mediastinum or main bronchus. Ann Thorac Surg 62:1016–1020, 1996PubMedCrossRefGoogle Scholar
  10. Quraishi MA, Costanzi JJ, Hokanson J: The natural history of lung cancer with pericardial metastases. Cancer 51:740–742, 1983PubMedCrossRefGoogle Scholar
  11. Sagawa M, Saito Y, Takahashi S, et al: Clinical and prognostic assessment of patients with resected small peripheral lung cancer lesions. Cancer 66:2653–2657, 1990PubMedCrossRefGoogle Scholar
  12. Sagawa M, Sakurada A, Fujimura S, et al: Five-year survivors with resected pN2 non-small cell lung carcinoma. Cancer 85:864–868, 1999PubMedCrossRefGoogle Scholar
  13. Saito Y, Nagamoto N, Ota S-I, et al: Results of surgical treatment for roentgenographically occult bronchogenic squamous cell carcinoma. J Thorac Cardiovasc Surg 104:401–407, 1992PubMedGoogle Scholar
  14. Travis WD, Colby TV, Corrin B, et al: Histologic typing of lung and pleural tumors. In World Health Organization Pathology Panel (Ed.): World Health Organization International Histological Classification of Tumors, 3rd ed. Berlin: Springer-Verlag, 5, 1999Google Scholar
  15. van Velzen E, Snijder RJ, de la Riviere AB, Elbert HJJ, van den Bosch JM: Type of lymph node involvement influences survival rates of T1N1M0 non-small cell lung carcinoma: lymph node involvement by direct extension compared with lobar and hilar node metastases. Chest 110:1469–1473, 1996PubMedCrossRefGoogle Scholar
  16. Weksler B, Bains M, Burt M, et al: Resection of lung cancer invading the diaphragm. J Thorac Cardiovasc Surg 114:500–501, 1997PubMedCrossRefGoogle Scholar
  17. Werner-Wasik M, Scott C, Cox JD, et al: Recursive partitioning analysis of 1999 Radiation Therapy Oncology Group (RTOG) patients with locally-advanced non-small cell lung cancer (LA-NSCLC): identification of five groups with different survival. Int J Radiat Oncol Biol Phys 48:1475–1482, 2000PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2002

Authors and Affiliations

  • American Joint Committee on Cancer
    • 1
  1. 1.Executive OfficeChicagoUSA

Personalised recommendations